Atorvastatin and Beta Cell Function in Type 1 Diabetes
Author Information
Author(s): Martin Stephan, Herder Christian, Schloot Nanette C., Koenig Wolfgang, Heise Tim, Heinemann Lutz, Kolb Hubert
Primary Institution: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
Hypothesis
Does atorvastatin treatment affect the decline of residual beta cell function in recent-onset type 1 diabetes?
Conclusion
Atorvastatin treatment did not significantly preserve beta cell function, although there may have been a slower decline of beta-cell function which merits further study.
Supporting Evidence
- Median fasting serum C-peptide levels dropped significantly in the placebo group but remained stable in the atorvastatin group.
- Median stimulated C-peptide concentrations declined in both groups, but the atorvastatin group did not show further deterioration by month 18.
- Atorvastatin treatment led to significant decreases in total cholesterol and C-reactive protein levels.
Takeaway
This study looked at whether a cholesterol-lowering drug called atorvastatin could help keep insulin-producing cells working longer in people with a new diagnosis of type 1 diabetes. It found that while atorvastatin didn't make a big difference, it might slow down the loss of these cells.
Methodology
The study was a randomized, double-blind, placebo-controlled trial involving 89 patients who received either atorvastatin or placebo for 18 months, with primary outcomes measured by stimulated serum C-peptide levels.
Potential Biases
There may be biases related to the low recruitment rate and the exclusion of patients who did not meet inclusion criteria.
Limitations
The actual number of patients recruited was lower than planned, which may affect the study's power and results.
Participant Demographics
Mean age was 30 years, with 40% females, and all participants were of Caucasian ethnicity.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website